Hadassah Drug to Fight Fatty Liver Disease Progressing Well in US Clinical Trials

Clinical trials with a Hadassah-developed technology to treat fatty liver disease are moving forward in 25 medical centers, in the United States and Australia. Fatty liver disease, in its severe form–called non-alcoholic steatohepatitis (NASH)–can lead to cirrhosis and liver cancer…